Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:28 +0200Wed, 19 Jun 2024 15:07:00 +0200Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xigduoHuman medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xigduoWed, 19 Jun 2024 15:07:00 +0200Human medicineXigduo : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-2672-summary_en.pdfXigduo : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-2672-summary_en.pdfThu, 29 Aug 2019 01:00:00 +0200Human medicine